Could We Maintain the Initial Efficacy of Triple Sequential Combination Therapies with Selexipag Against Progressive Deterioration Risk in Patients with Pulmonary Arterial Hypertension: Insights from a Single-Center Study?

Hacer Ceren Tokgöz, Cihangir Kaymaz, Barkın Kültürsay, Seda Tanyeri, Çağdaş Buluş, Dicle Sırma, Şeyma Zeynep Atıcı, Metehan Kibar, Ayşenur Küçük, Şeyma Nur Çiçek, Aziz Vezir, Can Erdem, Furkan Baturalp Erdoğan, Fatih Doğan, Aykun Hakgör